Tag archives


Publisher:  All-Party Parliamentary Group on HIV and AIDS

This report is the product of an almost year-long inquiry into the availability and affordability of drugs and diagnostics across the developing world. According to the All-Party Parliamentary Group on HIV and AIDS, despite notable success in the global AIDS response, access to medicines is threatened by withdrawal of funding in middle-income countries, the imposition of ever stricter rules on intellectual property, a failure to reach key population groups like LGBT people, sex workers and people who inject drugs, and insufficient R&D for child-friendly anti-retrovirals and treatments for HIV co-infections like TB.

Access Denied report calls for:

Review of funding decisions affecting middle income countries Global Fund leadership on Hepatitis C treatment Action to support use of TRIPS flexibilities to overcome high medicine prices Review of patent-ba...
This entry was posted in and tagged on by .

Publisher: Health GAP

An international civil society letter endorsed by 220 organisations, recommending that Dr Mark Dybul stop pursuing an initiative on tiered pricing to address the lack of access to affordable medicines in middle income countries.

Mark Dybul’s response
Equitable Access Initiative proposal
Critical analysis of the Equitable Access Initiative

This entry was posted in and tagged on by .